Bone repair material
View Patent ↗The bone repair material comprises the following components: A) a first granular component with a diameter larger than 20 μm chosen from the group of: calcium phosphate, calcium pyrophosphate, or calcium sulfate dihydrate; B) a second component chosen from the group of apatite powder with a particle diameter smaller than 1 μm, (preferably smaller than 100 nm); and B) a third component comprising water or an aqueous solution, whereby C) the volume fraction of the second and third component represents at least 35 volume-% of the total bone repair material.
1. A bone repair material comprising a mixture of:
A) a first granular component having a diameter larger than 20 μm selected from the group consisting of: calcium phosphate, calcium pyrophosphate and calcium sulfate dihydrate;
B) a second component consisting of apatite powder having a particle diameter smaller than 1 μm; and
C) a third component comprising water or an aqueous solution;
wherein the second component and the third component collectively represent at least 35 volume-% of the total bone repair material,
wherein the bone repair material forms a paste when the first, second and third components are mixed together to form the mixture,
wherein the bone repair material does not contain a hydrogel, and
wherein the first granular component provides a scaffold on which bone cells can anchor and proliferate when the bone repair material is used to repair a defect in a bone filled with an aqueous body fluid.
2. The bone repair material according to claim 1 , wherein the first component is selected from the group consisting of β-tricalcium phosphate, α-tricalcium phosphate, hydroxyapatite, tetracalcium phosphate, DCPD [dicalcium phosphate dihydrate (CaHPO 4 .2H 2 O)], DCP [dicalcium phosphate (CaHPO 4 )], OCP [octocalcium phosphate (Ca 8 H 2 (PO 4 ) 6 .5H 2 O)], α-CPP [α-calcium pyrophosphate (Ca 2 P 2 O 7 )], β-CPP [β-calcium pyrophosphate (Ca 2 P 2 O 7 )], γ-CPP [γ-calcium pyrophosphate (Ca 2 P 2 O 7 )], and CSD [calcium sulfate dihydrate (CaSO 4 .2H 2 O)].
3. The bone repair material according to claim 1 , wherein the diameter of said first granular component is larger than 100 microns.
4. The bone repair material according to claim 1 , wherein the diameter of said first granular component is smaller than 200 microns.
5. The bone repair material according to claim 1 , wherein the second component and the third component collectively represent 77 to 83 volume-% of the total bone repair material.
6. The bone repair material according to claim 1 , wherein the apatite powder is selected from the group consisting of calcium-deficient hydroxyapatite, hydroxyapatite and fluoroapatite.
7. The bone repair material according to claim 1 , wherein the first component comprises a mixture of several fractions of monodispersed granules of different size.
8. The bone repair material according to claim 7 , wherein a size ratio of any two fractions of monodispersed granules of different size is larger than 1.5.
9. The bone repair material according to claim 1 , wherein the granules of the first component are macroporous, with a pore diameter greater than 0.05 mm.
10. The bone repair material according to claim 1 , wherein the granules of the first component have a porosity of less than 90%.
11. The bone repair material according to claim 1 , wherein said granules of said first component have an apparent volume smaller than 30%.
12. The bone repair material according to claim 1 , wherein the granules of the first component are spherical.
13. The bone repair material according to claim 1 , wherein the granules of the first component are concave.
14. The bone repair material according to claim 1 , wherein the apatite powder comprises deagglomerated powder particles.
15. The bone repair material according to claim 1 , wherein the amount of said third component expressed in milliliters divided by the sum of the amounts of said first component and said second component expressed in grams is in the range of 0.1 to 0.7 mL/g.
16. The bone repair material according to claim 1 , wherein the volume ratio between the third and the first component is in the range of 3.0 to 3.4.
17. The bone repair material according to claim 1 further comprising an additive increasing the surface charge of the particles present in the formulation.
18. The bone repair material according to claim 17 , wherein said additive is a carboxylated compound having citrate or poly(carboxylated) ions.
19. The bone repair material according to claim 1 , wherein said third component has an ionic strength of 0.15 M or higher.
20. The bone repair material according to claim 1 further comprising one or more drugs comprising a pharmaceutical or physiologically active substance useful in the treatment of bone defects or bone diseases.
21. The bone repair material according to claim 1 further comprising an inorganic inhibitor for apatite dissolution and growth, said inorganic inhibitor being magnesium or pyrophosphate ions.
22. The bone repair material according to claim 1 further comprising an organic inhibitor for apatite dissolution and growth, said organic inhibitor being citrate ions, amino acids, peptides or proteins.
23. The bone repair material according to claim 1 , wherein the bone repair material is a ready mixed putty material.
24. The bone repair material according to claim 1 , wherein said first component and second component are a dry mixture to which the third component is to be added before use.
25. The bone repair material according to claim 24 , wherein the third component comprises blood, bone marrow, plasma, platelet-rich plasma or concentrated bone marrow cells.
26. The bone repair material according to claim 1 , wherein said second component and third component are a nanocrystalline paste to which the first component is admixed before use.
27. The bone repair material according to claim 1 , wherein said third component comprises a fluid extracted from the patient without or with additional processing, and wherein the fluid extracted from the patient is blood, bone marrow, plasma, platelet-rich plasma or concentrated bone marrow cells.
28. The bone repair material according to claim 1 , wherein said third component further comprises cells with osteogenic potential that have been cultivated and/or differentiated prior to their use.
29. The bone repair material according to claim 28 , wherein said cells are embryonic stem cells, stem cells, bone marrow cells or osteoblasts.
30. The bone repair material according to claim 1 further comprising a radiopacifier.